Detalhe da pesquisa
1.
Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.
Haematologica
; 2024 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38899352
2.
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer.
Clin Infect Dis
; 76(4): 674-682, 2023 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906831
3.
[Mobilization and conditioning protocols actualization for autologous stem cell transplantation for autoimmune diseases: Guidelines from MATHEC-SFGM-TC]. / Actualisation des protocoles de mobilisation et conditionnement pour la pratique des autogreffes de cellules souches hématopoïétiques chez les patients atteints de maladies auto-immunes : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (MATHEC-SFGM-TC).
Bull Cancer
; 111(2S): S84-S95, 2024 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-37845095
4.
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma.
Nat Med
; 28(10): 2145-2154, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36138152